Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C
Open Access
- 25 January 2011
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 104 (4) , 673-684
Abstract
Expression of protein kinase C alpha (PKCα) is elevated in prostate cancer (PCa); thus, we have studied whether the development of tumourigenesis in prostate epithelial cell lines modifies the normal pattern of choline (Cho) metabolite release on PKC activation. Normal and tumourigenic human prostate epithelial cell lines were incubated with [3H]-Cho to label choline phospholipids. Protein kinase C was activated with phorbol ester and blocked with inhibitors. Choline metabolites were resolved by ion-exchange chromatography. Phospholipase D (PLD) activity was measured by transphosphatidylation. Protein expression was detected by western blotting and/or RT–PCR. Choline uptake was measured on cells in monolayers over 60 min. Normal prostate epithelial cell lines principally released phosphocholine (PCho) in contrast to tumourigenic lines, which released Cho. In addition, only with normal cell lines did PKC activation stimulate Cho metabolite release. Protein kinase C alpha expression varied between normal and tumourigenic cell lines but all showed a PKCα link to myristoylated alanine-rich C kinase substrate (MARCKS) protein. The five cell lines differed in Cho uptake levels, with normal PNT2C2 line cells showing highest uptake over 60 min incubation. Normal and tumourigenic cell lines expressed mRNA for PLD1 and PLD2, and showed similar levels of basal and PKC-activated PLD activity. The transition to tumourigenesis in prostate epithelial cell lines results in major changes to Cho metabolite release into the medium and PKC signalling to phosphatidylcholine turnover. The changes, which reflect the metabolic and proliferative needs of tumourigenic cells compared with untransformed cells, could be significant for both diagnosis and treatment.Keywords
This publication has 95 references indexed in Scilit:
- Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer CellsCancer Research, 2010
- Differential Role of Human Choline Kinase α and β Enzymes in Lipid Metabolism: Implications in Cancer Onset and TreatmentPLOS ONE, 2009
- Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerBritish Journal of Cancer, 2009
- Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cellsMolecular Cancer, 2009
- MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cellsExperimental Cell Research, 2008
- Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: Implications in cancer therapyThe International Journal of Biochemistry & Cell Biology, 2008
- Functional role of phosphatidylcholine‐specific phospholipase C in regulating CD16 membrane expression in natural killer cellsEuropean Journal of Immunology, 2007
- Targeting the protein kinase C family: are we there yet?Nature Reviews Cancer, 2007
- Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995